According to the Kidney Disease: Improving Global Outcomes (KDIGO) initiative and the European Kidney Best Practice group, anemia is defined as Hb ≤120 g/L in men and menopausal women and Hb ≤110 g/L in non-menopausal women (14, 15). This evidence concerns the gene GSTM1 and kidney disorder.